We thus measured OVA‐specific responses 7 days after the second VSV‐GP or DCVacc single and combination treatments in spleen and tumor tissue by measuring IFNγ‐producing CD8 T cells after in vitro OVA‐peptide stimulation. Here, CD8A is linked to neoplasm.